Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

December 1, 2014

LEMTRADA (Alemtuzumab) makes history (in Cullman, AL.) as the 11th MS Disease Modifying Medications being used in the USA

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
December 1, 2014 CULLMAN, Alabama – Today in a treatment room in the basement of a small medical building, Leah Quartano,…
MS Drug Therapies

November 30, 2014

Experimental Drug for RRMS, SPMS Enters Phase 2 Trial

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
November 24, 2014 Lexington, MA-based biopharmaceutical company Xenetic Biosciences, Inc. has just announced its new license partner Pharmsynthezhas completed dosing in its ongoing…
MS Drug Therapies

November 30, 2014

New Mouse Model Better Represents JC Virus That Infects MS Patients

  • Misc. MS Related
    /
  • MS Research Study and Reports
    /
  • Tysabri
    /
Posted by: Maureen Newman   November 24, 2014 Researchers in the laboratory of Steve Goldman, MD, PhD, Co-Director of University…
Misc. MS Related

November 30, 2014

Breakthrough discovery contributes towards future treatment of multiple sclerosis and autoimmune inflammation

  • MS Research Study and Reports
    /
A new type of T cell, TH-GM, produces a cytokine, GM-CSF, to recruit and activate other inflammatory cells, including macrophages,…
MS Research Study and Reports

November 30, 2014

Actavis Plans Generic Version of Acorda’s Multiple Sclerosis Drug Ampyra

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Posted by: Leonor Mateus Ferreira June 30, 2014 Acorda Therapeutics recently announced receiving a notice letter from pharmaceutical company Actavis Plc indicating their plans to commercialize a…
Alternative therapies and devices for Multiple Sclerosis (MS)

November 30, 2014

Orphan Drug Designation Granted to Treatment for Rare Multiple Sclerosis Drug Complication

  • Tysabri
    /
The Food and Drug Administration granted Orphan Drug Designation to Inhibikase Therapeutics’, Inc. lead product, IkT-001Pro (imatinib), to treat progressive multifocal leukoencephalopathy(PML). According…
Tysabri

November 30, 2014

Rare Brain Infection Death Spurs FDA To Update Warning Label for MS Drug

  • MS Drug Therapies
    /
  • Oral MS Medications
    /
  • Tysabri
    /
Posted by: Anna Tan, RN November 26, 2014 The US Food and Drug Administration has just issued a report warning the general public and…
MS Drug Therapies

November 28, 2014

Learn About LDN (Low Dose Naltrexone)

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • LDN
    /
        LDN International on Twitter – https://twitter.com/LDNIntl The most up to date resource for all research and development…
Alternative therapies and devices for Multiple Sclerosis (MS)

November 27, 2014

A COMPREHENSIVE MS Q&A Titled: “Everything You Wanted to Know about MS, BUT FORGOT to Ask”

  • MS Drug Therapies
    /
  • MS Educational Programs
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  • Multiple Sclerosis Videos
    /
“Everything You Wanted to Know about MS, BUT FORGOT to Ask” This program took place on November 22, 2014 in…
MS Drug Therapies

November 26, 2014

Seminar Synopsis of presentation by Jack Burks, MD on : “Invisible MS Symptoms”

  • MS Educational Programs
    /
  • Multiple Sclerosis Videos
    /
Program Date: November 8, 2014 Invisible Symptoms Many symptoms of MS are not visible to family, friends and colleagues. We…
MS Educational Programs

Categories

Latest Blog Posts